Dissecting the Contribution of the Ventral Hippocampus to (R,S)-Ketamine's Fear Buffering Effects
剖析腹侧海马对 (R,S)-氯胺酮恐惧缓冲效应的贡献
基本信息
- 批准号:10319316
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntidepressive AgentsAnxietyAttenuatedAwardBehaviorBehavioralBehavioral AssayBiologicalBuffersComplementDataDevelopmentDiseaseEnhancersExposure toFemaleFrightFutureGlutamatesGoalsGrowthHigh-Throughput RNA SequencingHippocampus (Brain)ImageInjectionsInstitutionKetamineKnowledgeLaboratoriesLatinaLeadLearningLinkLong-Term EffectsLongitudinal StudiesMajor Depressive DisorderMeasuresMediatingMemoryMental DepressionMental disordersMentorsMicrodialysisMicroscopyMolecularMusN-Methyl-D-Aspartate ReceptorsNeuronsNeurosciencesNeurotransmittersPatientsPharmaceutical PreparationsPharmacotherapyPhasePhysiologicalPositioning AttributePost-Traumatic Stress DisordersPostdoctoral FellowPredispositionPsychopathologyReportingResearchResearch PersonnelResearch Project GrantsRetrievalSerotoninShockSignal TransductionStimulusStressSymptomsTechniquesTestingTrainingWorkantidepressant effectawakebehavioral responsecareercomorbidityconditioned feardisabilityexperiencefootgamma-Aminobutyric Acidin vivoin vivo imaginginsightlarge scale datamaleneurochemistrynovelpreventresilienceresponseskillsstress disorderstress resiliencestressortooltranscriptomicstreatment-resistant depression
项目摘要
PROJECT SUMMARY / ABSTRACT
Though stress is necessary for the adaptive survival of a species, stress exposure can also elicit maladaptive
physiological and behavioral responses. Stress-induced maladaptive responses may lead to subsequent
development of psychiatric disorders such as post-traumatic stress disorder (PTSD) and major depressive
disorder (MDD). A core symptom observed in these disorders is increased fear expression, as defined by
heightened fear responses in the presence of stimuli associated with fear. We have previously discovered that
a single injection of (R,S)-ketamine, a rapid-acting antidepressant, attenuates learned fear following contextual
fear conditioning (CFC). We and others have reported that the ventral hippocampus (vHPC), specifically
ventral CA3 (vCA3), mediates (R,S)-ketamine’s effects on attenuating learned fear. However, how exactly
(R,S)-ketamine modulates the ensembles in vCA3 to decrease fear generalization is yet to be explored. It has
additionally been shown that ventral CA1 (vCA1) contributes to fear behavior. Thus, this research plan will lay
the groundwork to uncover the effects of (R,S)-ketamine administration on fear behavior using of in vivo
microdialysis to complement and further explain the data already collected from in vivo Ca2+ imaging in vCA3
and vCA1. Overall, my goal for this proposal is to better understand how (R,S)-ketamine alters
neurotransmitters and neuronal ensembles to buffer against heightened fear expression. My preliminary
findings outlined in Aim 1 show that (R,S)-ketamine: 1) blunts responses to shocks during fear encoding
specifically in vCA3; 2) differentially affects activity in ventral hippocampal regions CA3 and CA1; and 3)
decreases correlated activity in the ventral hippocampus during both fear encoding and retrieval. Together,
these findings lead me to my hypothesis that there are distinct changes in neurotransmitter content
immediately following (R,S)-ketamine administration that are long-lasting and that blunt the experience of a
fearful stressor. However, to test this hypothesis, I need to utilize in vivo microdialysis as outlined in Aim 2 to
measure levels of glutamate, gamma-aminobutyric acid (GABA), and serotonin (5-HT) in vCA3 or vCA1 of
male and female mice to understand how they potentially mediate (R,S)-ketamine’s effects. To date, no
longitudinal studies utilizing in vivo Ca2+ imaging or in vivo microdialysis studies have yet been performed
investigating (R,S)-ketamine effects on fear behavior. In Aim 3, I describe a postdoctoral research direction to
accomplish my goal of understanding the biological substrates of stress resilience. I have gained experience in
behavior, in vivo techniques, cellular and molecular neuroscience, and microscopy. However, I have yet to
conduct techniques that manipulate circuits, or that probe the contribution of transcriptomic changes after drug
treatment or with stress. Thus, I plan to address these gaps in my knowledge by finding a post-doctoral
position that allows me to grow in these skills. In summary, this proposal will lead to the development of a
diverse skillset in order to become a successful independent researcher in the psychiatric field.
项目概要/摘要
虽然压力对于一个物种的适应性生存是必要的,但压力暴露也会引起适应不良
压力引起的适应不良反应可能会导致后续的反应。
精神疾病的发展,例如创伤后应激障碍(PTSD)和重度抑郁症
这些疾病中观察到的核心症状是恐惧表达增加,定义为:
我们之前发现,在存在与恐惧相关的刺激时,会出现完全的恐惧反应。
单次注射(R,S)-氯胺酮(一种速效抗抑郁药)可减轻情境后的习得性恐惧
我们和其他人已经报道了腹侧海马(vHPC)。
腹侧 CA3 (vCA3) 介导 (R,S)-氯胺酮对减弱习得性恐惧的作用,但具体如何发挥作用。
(R,S)-氯胺酮调节 vCA3 中的整体以减少恐惧泛化尚待探索。
另外还表明,腹侧 CA1 (vCA1) 会导致恐惧行为,因此,该研究计划将奠定基础。
为揭示 (R,S)-氯胺酮给药对体内恐惧行为的影响奠定了基础
微透析补充和进一步解释已从 vCA3 体内 Ca2+ 成像中收集的数据
总体而言,我此提案的目标是更好地了解 (R,S)-氯胺酮如何改变。
神经递质和神经系统可以缓冲呼气分析仪的恐惧表达。
目标 1 中概述的发现表明,(R,S)-氯胺酮:1) 在恐惧编码过程中对电击的反应迟钝
特别是在 vCA3 中;2) 对腹侧海马区 CA3 和 CA1 的活动有不同的影响;3)
减少恐惧编码和检索过程中腹侧海马的相关活动。
这些发现使我得出了这样的假设:神经递质含量发生了明显的变化
(R,S)-氯胺酮给药后立即服用,这种药物是持久的并且会减弱患者的体验
然而,为了检验这个假设,我需要利用目标 2 中概述的体内微透析来
测量 vCA3 或 vCA1 中谷氨酸、γ-氨基丁酸 (GABA) 和血清素 (5-HT) 的水平
雄性和雌性小鼠,以了解它们如何潜在地介导(R,S)-氯胺酮的作用。
利用体内 Ca2+ 成像或体内微透析研究的纵向研究尚未进行
调查 (R,S)-氯胺酮对恐惧行为的影响 在目标 3 中,我描述了一个博士后研究方向。
实现了我了解压力恢复的生物基础的目标,我在这方面获得了经验。
行为学、体内技术、细胞和分子神经科学以及显微镜学。
进行操纵电路的技术,或探索药物后转录组变化的贡献
因此,我计划通过寻找博士后来解决我的知识差距。
总而言之,该提案将导致我发展这些技能。
多样化的技能,以成为精神病学领域成功的独立研究员。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice.
预防性 (R,S)-氯胺酮对青春期小鼠的压力诱发行为有效,但对老年小鼠无效。
- DOI:
- 发表时间:2022-06-21
- 期刊:
- 影响因子:0
- 作者:Mastrodonato, Alessia;Pavlova, Ina;Kee, Noelle C;Pham, Van Anh;McGowan, Josephine C;Mann, J John;Denny, Christine A
- 通讯作者:Denny, Christine A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Josephine McGowan其他文献
Josephine McGowan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Josephine McGowan', 18)}}的其他基金
Elucidating the mechanisms underlying ketamine-induced protection against fear overgeneralization
阐明氯胺酮诱导的针对恐惧过度概括的保护机制
- 批准号:
9911605 - 财政年份:2020
- 资助金额:
$ 4.2万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Therapy-induced cognitive impairment in a rat model of prostate cancer
前列腺癌大鼠模型中治疗引起的认知障碍
- 批准号:
10766874 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
in vivo investigation of KOR as a marker of BPD and suicide related endophenotypes
KOR 作为 BPD 和自杀相关内表型标志物的体内研究
- 批准号:
10735604 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
CRSNS: Development of EEG/MEG Source Reconstruction with Fast Multipole Method
CRSNS:使用快速多极方法进行 EEG/MEG 源重建的开发
- 批准号:
10835137 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
1/2 Large-scale, single-cell characterization of molecular and cellular networks of mood regulation circuitry in major depressive disorder
1/2 重度抑郁症情绪调节回路的分子和细胞网络的大规模单细胞表征
- 批准号:
10744931 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
A Feasibility Study of a Novel, Fully Remote Counseling and Sound Therapy Program for Hyperacusis
新型、完全远程咨询和听觉过敏声音治疗计划的可行性研究
- 批准号:
10651126 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别: